Israel Englander Eye Point Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 30,800 shares of EYPT stock, worth $321,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,800

Previous 446,199 93.1%

Holding current value

$321,860

Previous $3.32 Million 95.01%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$5.42 - $9.22 $2.25 Million - $3.83 Million	-415,399 Reduced 93.1%	30,800 $166,000
Q4 2024 Feb 14, 2025	BUY	$7.02 - $12.12 $3.13 Million - $5.41 Million	446,199 New	446,199 $3.32 Million
Q2 2024 Aug 14, 2024	SELL	$8.16 - $22.89 $12 Million - $33.6 Million	-1,465,722 Reduced 71.62%	580,716 $5.05 Million
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $18.3 Million - $27.3 Million	917,800 Added 81.32%	2,046,438 $42.3 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $4.51 Million - $19.1 Million	789,691 Added 232.98%	1,128,638 $26.1 Million
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $824,859 - $2.45 Million	-272,231 Reduced 44.54%	338,947 $2.95 Million
Q1 2023 May 15, 2023	SELL	$2.28 - $5.04 $146,501 - $323,845	-64,255 Reduced 9.51%	611,178 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $628,398 - $1.91 Million	265,147 Added 64.62%	675,433 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $466,758 - $745,740	67,063 Added 19.54%	410,286 $3.25 Million

Others Institutions Holding EYPT

# of Institutions

167

Shares Held

71.7M

Call Options Held

232K

Put Options Held

207K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $356M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account